Gene editing startup Inscripta pulls in $20 mln
Boulder, Colorado-based Inscripta, a gene-editing startup, has raised $20 million in funding. The investors were Venrock, Foresite, Mérieux Développement, Paladin Capital Group, MLS Capital and NanoDimension.
4 April 2019•1 min read
